nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—AR—breast cancer	0.14	0.544	CbGaD
Cyproterone acetate—CYP19A1—breast cancer	0.117	0.456	CbGaD
Cyproterone acetate—Megestrol acetate—Fluoxymesterone—breast cancer	0.108	0.529	CrCrCtD
Cyproterone acetate—Medroxyprogesterone Acetate—Fluoxymesterone—breast cancer	0.0957	0.471	CrCrCtD
Cyproterone acetate—CYP19A1—Exemestane—breast cancer	0.0703	0.198	CbGbCtD
Cyproterone acetate—AR—Fluoxymesterone—breast cancer	0.0696	0.195	CbGbCtD
Cyproterone acetate—CYP19A1—Letrozole—breast cancer	0.0598	0.168	CbGbCtD
Cyproterone acetate—CYP19A1—Anastrozole—breast cancer	0.0533	0.15	CbGbCtD
Cyproterone acetate—NR3C1—Fluoxymesterone—breast cancer	0.0443	0.124	CbGbCtD
Cyproterone acetate—CYP19A1—Raloxifene—breast cancer	0.0269	0.0757	CbGbCtD
Cyproterone acetate—CYP19A1—Tamoxifen—breast cancer	0.0178	0.05	CbGbCtD
Cyproterone acetate—CYP19A1—Paclitaxel—breast cancer	0.0139	0.0389	CbGbCtD
Cyproterone acetate—CYP19A1—corpus luteum—breast cancer	0.00648	0.343	CbGeAlD
Cyproterone acetate—AR—nipple—breast cancer	0.000735	0.0389	CbGeAlD
Cyproterone acetate—NR3C1—nipple—breast cancer	0.000532	0.0282	CbGeAlD
Cyproterone acetate—CYP19A1—endometrium—breast cancer	0.000501	0.0265	CbGeAlD
Cyproterone acetate—AR—epithelium—breast cancer	0.000495	0.0262	CbGeAlD
Cyproterone acetate—Ethynodiol—PGR—breast cancer	0.00048	0.242	CrCbGaD
Cyproterone acetate—AR—skin of body—breast cancer	0.000471	0.0249	CbGeAlD
Cyproterone acetate—CYP19A1—uterus—breast cancer	0.000462	0.0244	CbGeAlD
Cyproterone acetate—CYP19A1—adipose tissue—breast cancer	0.000452	0.0239	CbGeAlD
Cyproterone acetate—AR—endometrium—breast cancer	0.000444	0.0235	CbGeAlD
Cyproterone acetate—NR3C1—embryo—breast cancer	0.000439	0.0232	CbGeAlD
Cyproterone acetate—CYP19A1—female reproductive system—breast cancer	0.000415	0.022	CbGeAlD
Cyproterone acetate—AR—uterus—breast cancer	0.000409	0.0216	CbGeAlD
Cyproterone acetate—CYP19A1—adrenal gland—breast cancer	0.000405	0.0214	CbGeAlD
Cyproterone acetate—AR—pituitary gland—breast cancer	0.000402	0.0213	CbGeAlD
Cyproterone acetate—AR—adipose tissue—breast cancer	0.0004	0.0212	CbGeAlD
Cyproterone acetate—CYP19A1—female gonad—breast cancer	0.000378	0.02	CbGeAlD
Cyproterone acetate—AR—female reproductive system—breast cancer	0.000368	0.0195	CbGeAlD
Cyproterone acetate—AR—adrenal gland—breast cancer	0.000359	0.019	CbGeAlD
Cyproterone acetate—NR3C1—epithelium—breast cancer	0.000358	0.019	CbGeAlD
Cyproterone acetate—CYP19A1—endocrine gland—breast cancer	0.000351	0.0186	CbGeAlD
Cyproterone acetate—Megestrol acetate—PGR—breast cancer	0.000351	0.177	CrCbGaD
Cyproterone acetate—NR3C1—skin of body—breast cancer	0.000341	0.018	CbGeAlD
Cyproterone acetate—AR—female gonad—breast cancer	0.000335	0.0177	CbGeAlD
Cyproterone acetate—NR3C1—endometrium—breast cancer	0.000321	0.017	CbGeAlD
Cyproterone acetate—AR—endocrine gland—breast cancer	0.000311	0.0165	CbGeAlD
Cyproterone acetate—Ethynodiol—ESR1—breast cancer	0.000303	0.153	CrCbGaD
Cyproterone acetate—NR3C1—uterus—breast cancer	0.000296	0.0157	CbGeAlD
Cyproterone acetate—NR3C1—pituitary gland—breast cancer	0.000291	0.0154	CbGeAlD
Cyproterone acetate—NR3C1—adipose tissue—breast cancer	0.00029	0.0153	CbGeAlD
Cyproterone acetate—NR3C1—female reproductive system—breast cancer	0.000266	0.0141	CbGeAlD
Cyproterone acetate—NR3C1—adrenal gland—breast cancer	0.00026	0.0137	CbGeAlD
Cyproterone acetate—NR3C1—bone marrow—breast cancer	0.000251	0.0133	CbGeAlD
Cyproterone acetate—CYP19A1—lymph node—breast cancer	0.000243	0.0129	CbGeAlD
Cyproterone acetate—NR3C1—female gonad—breast cancer	0.000242	0.0128	CbGeAlD
Cyproterone acetate—NR3C1—endocrine gland—breast cancer	0.000225	0.0119	CbGeAlD
Cyproterone acetate—AR—lymph node—breast cancer	0.000215	0.0114	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—PGR—breast cancer	0.000204	0.103	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—SHBG—breast cancer	0.000191	0.0962	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—AR—breast cancer	0.000167	0.0843	CrCbGaD
Cyproterone acetate—NR3C1—lymph node—breast cancer	0.000156	0.00824	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—ESR1—breast cancer	0.000129	0.065	CrCbGaD
Cyproterone acetate—Megestrol acetate—ABCB1—breast cancer	9.4e-05	0.0474	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—CYP3A4—breast cancer	6.58e-05	0.0332	CrCbGaD
Cyproterone acetate—Tachycardia—Docetaxel—breast cancer	1.81e-05	0.000166	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Paclitaxel—breast cancer	1.8e-05	0.000166	CcSEcCtD
Cyproterone acetate—Skin disorder—Docetaxel—breast cancer	1.8e-05	0.000165	CcSEcCtD
Cyproterone acetate—Oedema—Capecitabine—breast cancer	1.8e-05	0.000165	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Paclitaxel—breast cancer	1.79e-05	0.000164	CcSEcCtD
Cyproterone acetate—Diarrhoea—Gemcitabine—breast cancer	1.79e-05	0.000164	CcSEcCtD
Cyproterone acetate—Renal failure—Doxorubicin—breast cancer	1.78e-05	0.000164	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Methotrexate—breast cancer	1.78e-05	0.000163	CcSEcCtD
Cyproterone acetate—Dizziness—Irinotecan—breast cancer	1.77e-05	0.000163	CcSEcCtD
Cyproterone acetate—Haemoglobin—Epirubicin—breast cancer	1.77e-05	0.000163	CcSEcCtD
Cyproterone acetate—Jaundice—Doxorubicin—breast cancer	1.77e-05	0.000162	CcSEcCtD
Cyproterone acetate—Anorexia—Docetaxel—breast cancer	1.77e-05	0.000162	CcSEcCtD
Cyproterone acetate—Shock—Capecitabine—breast cancer	1.77e-05	0.000162	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Capecitabine—breast cancer	1.76e-05	0.000162	CcSEcCtD
Cyproterone acetate—Hepatitis—Epirubicin—breast cancer	1.76e-05	0.000162	CcSEcCtD
Cyproterone acetate—Haemorrhage—Epirubicin—breast cancer	1.76e-05	0.000162	CcSEcCtD
Cyproterone acetate—Eye disorder—Methotrexate—breast cancer	1.76e-05	0.000161	CcSEcCtD
Cyproterone acetate—Diarrhoea—Fluorouracil—breast cancer	1.76e-05	0.000161	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Capecitabine—breast cancer	1.76e-05	0.000161	CcSEcCtD
Cyproterone acetate—Tachycardia—Capecitabine—breast cancer	1.75e-05	0.000161	CcSEcCtD
Cyproterone acetate—Skin disorder—Capecitabine—breast cancer	1.74e-05	0.00016	CcSEcCtD
Cyproterone acetate—Sweating—Doxorubicin—breast cancer	1.74e-05	0.00016	CcSEcCtD
Cyproterone acetate—Urticaria—Paclitaxel—breast cancer	1.74e-05	0.00016	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Capecitabine—breast cancer	1.74e-05	0.000159	CcSEcCtD
Cyproterone acetate—Hypotension—Docetaxel—breast cancer	1.73e-05	0.000159	CcSEcCtD
Cyproterone acetate—Haematuria—Doxorubicin—breast cancer	1.73e-05	0.000159	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Epirubicin—breast cancer	1.73e-05	0.000159	CcSEcCtD
Cyproterone acetate—Body temperature increased—Paclitaxel—breast cancer	1.73e-05	0.000159	CcSEcCtD
Cyproterone acetate—Abdominal pain—Paclitaxel—breast cancer	1.73e-05	0.000159	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Doxorubicin—breast cancer	1.72e-05	0.000158	CcSEcCtD
Cyproterone acetate—Anorexia—Capecitabine—breast cancer	1.71e-05	0.000157	CcSEcCtD
Cyproterone acetate—Angiopathy—Methotrexate—breast cancer	1.71e-05	0.000157	CcSEcCtD
Cyproterone acetate—Vomiting—Mitoxantrone—breast cancer	1.71e-05	0.000157	CcSEcCtD
Cyproterone acetate—Vomiting—Irinotecan—breast cancer	1.71e-05	0.000157	CcSEcCtD
Cyproterone acetate—Immune system disorder—Methotrexate—breast cancer	1.7e-05	0.000156	CcSEcCtD
Cyproterone acetate—Dizziness—Fluorouracil—breast cancer	1.7e-05	0.000156	CcSEcCtD
Cyproterone acetate—Visual impairment—Epirubicin—breast cancer	1.7e-05	0.000156	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methotrexate—breast cancer	1.7e-05	0.000156	CcSEcCtD
Cyproterone acetate—Rash—Mitoxantrone—breast cancer	1.69e-05	0.000155	CcSEcCtD
Cyproterone acetate—Rash—Irinotecan—breast cancer	1.69e-05	0.000155	CcSEcCtD
Cyproterone acetate—Dermatitis—Mitoxantrone—breast cancer	1.69e-05	0.000155	CcSEcCtD
Cyproterone acetate—Dermatitis—Irinotecan—breast cancer	1.69e-05	0.000155	CcSEcCtD
Cyproterone acetate—Chills—Methotrexate—breast cancer	1.69e-05	0.000155	CcSEcCtD
Cyproterone acetate—Headache—Irinotecan—breast cancer	1.68e-05	0.000154	CcSEcCtD
Cyproterone acetate—Headache—Mitoxantrone—breast cancer	1.68e-05	0.000154	CcSEcCtD
Cyproterone acetate—Hypotension—Capecitabine—breast cancer	1.68e-05	0.000154	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	1.67e-05	0.000314	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—JUN—breast cancer	1.67e-05	0.000314	CbGpPWpGaD
Cyproterone acetate—Erythema multiforme—Epirubicin—breast cancer	1.66e-05	0.000153	CcSEcCtD
Cyproterone acetate—Alopecia—Methotrexate—breast cancer	1.66e-05	0.000153	CcSEcCtD
Cyproterone acetate—Vomiting—Gemcitabine—breast cancer	1.66e-05	0.000153	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—breast cancer	1.66e-05	0.000311	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.66e-05	0.000311	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Docetaxel—breast cancer	1.65e-05	0.000152	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—breast cancer	1.65e-05	0.00031	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—breast cancer	1.65e-05	0.00031	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Methotrexate—breast cancer	1.65e-05	0.000151	CcSEcCtD
Cyproterone acetate—Rash—Gemcitabine—breast cancer	1.65e-05	0.000151	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—CTNNB1—breast cancer	1.65e-05	0.00031	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC2A5—breast cancer	1.65e-05	0.00031	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLCO1B1—breast cancer	1.65e-05	0.00031	CbGpPWpGaD
Cyproterone acetate—Dermatitis—Gemcitabine—breast cancer	1.65e-05	0.000151	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—breast cancer	1.65e-05	0.000309	CbGpPWpGaD
Cyproterone acetate—Eye disorder—Epirubicin—breast cancer	1.65e-05	0.000151	CcSEcCtD
Cyproterone acetate—Malnutrition—Methotrexate—breast cancer	1.64e-05	0.00015	CcSEcCtD
Cyproterone acetate—Haemoglobin—Doxorubicin—breast cancer	1.64e-05	0.00015	CcSEcCtD
Cyproterone acetate—Headache—Gemcitabine—breast cancer	1.64e-05	0.00015	CcSEcCtD
Cyproterone acetate—Vomiting—Fluorouracil—breast cancer	1.63e-05	0.00015	CcSEcCtD
Cyproterone acetate—Dyspepsia—Docetaxel—breast cancer	1.63e-05	0.00015	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PARP1—breast cancer	1.63e-05	0.000306	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH3—breast cancer	1.63e-05	0.000306	CbGpPWpGaD
Cyproterone acetate—Hepatitis—Doxorubicin—breast cancer	1.63e-05	0.00015	CcSEcCtD
Cyproterone acetate—Haemorrhage—Doxorubicin—breast cancer	1.63e-05	0.00015	CcSEcCtD
Cyproterone acetate—Rash—Fluorouracil—breast cancer	1.62e-05	0.000149	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—SMAD4—breast cancer	1.62e-05	0.000304	CbGpPWpGaD
Cyproterone acetate—Dermatitis—Fluorouracil—breast cancer	1.62e-05	0.000149	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—VDR—breast cancer	1.62e-05	0.000304	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—breast cancer	1.62e-05	0.000304	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Docetaxel—breast cancer	1.61e-05	0.000148	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Paclitaxel—breast cancer	1.61e-05	0.000148	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.61e-05	0.000303	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	1.61e-05	0.000303	CbGpPWpGaD
Cyproterone acetate—Headache—Fluorouracil—breast cancer	1.61e-05	0.000148	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—CDKN1A—breast cancer	1.61e-05	0.000302	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.61e-05	0.000302	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—YBX1—breast cancer	1.61e-05	0.000302	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Docetaxel—breast cancer	1.6e-05	0.000147	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Doxorubicin—breast cancer	1.6e-05	0.000147	CcSEcCtD
Cyproterone acetate—Dyspnoea—Capecitabine—breast cancer	1.6e-05	0.000147	CcSEcCtD
Cyproterone acetate—Fatigue—Docetaxel—breast cancer	1.6e-05	0.000147	CcSEcCtD
Cyproterone acetate—Angiopathy—Epirubicin—breast cancer	1.6e-05	0.000147	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.6e-05	0.0003	CbGpPWpGaD
Cyproterone acetate—Nausea—Irinotecan—breast cancer	1.59e-05	0.000146	CcSEcCtD
Cyproterone acetate—Nausea—Mitoxantrone—breast cancer	1.59e-05	0.000146	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—APRT—breast cancer	1.59e-05	0.000299	CbGpPWpGaD
Cyproterone acetate—Immune system disorder—Epirubicin—breast cancer	1.59e-05	0.000146	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Epirubicin—breast cancer	1.59e-05	0.000146	CcSEcCtD
Cyproterone acetate—Constipation—Docetaxel—breast cancer	1.59e-05	0.000146	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—breast cancer	1.58e-05	0.000298	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Capecitabine—breast cancer	1.58e-05	0.000145	CcSEcCtD
Cyproterone acetate—Chills—Epirubicin—breast cancer	1.58e-05	0.000145	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—NCOR1—breast cancer	1.57e-05	0.000295	CbGpPWpGaD
Cyproterone acetate—Visual impairment—Doxorubicin—breast cancer	1.57e-05	0.000144	CcSEcCtD
Cyproterone acetate—Asthenia—Paclitaxel—breast cancer	1.57e-05	0.000144	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—PABPC1—breast cancer	1.57e-05	0.000295	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.56e-05	0.000293	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Capecitabine—breast cancer	1.56e-05	0.000143	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—breast cancer	1.56e-05	0.000293	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.56e-05	0.000293	CbGpPWpGaD
Cyproterone acetate—Alopecia—Epirubicin—breast cancer	1.56e-05	0.000143	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.56e-05	0.000292	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.55e-05	0.000292	CbGpPWpGaD
Cyproterone acetate—Nausea—Gemcitabine—breast cancer	1.55e-05	0.000143	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Capecitabine—breast cancer	1.55e-05	0.000142	CcSEcCtD
Cyproterone acetate—Fatigue—Capecitabine—breast cancer	1.55e-05	0.000142	CcSEcCtD
Cyproterone acetate—Pruritus—Paclitaxel—breast cancer	1.55e-05	0.000142	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR2—breast cancer	1.54e-05	0.00029	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—breast cancer	1.54e-05	0.00029	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Epirubicin—breast cancer	1.54e-05	0.000142	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Doxorubicin—breast cancer	1.54e-05	0.000141	CcSEcCtD
Cyproterone acetate—Constipation—Capecitabine—breast cancer	1.54e-05	0.000141	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EEF2—breast cancer	1.53e-05	0.000288	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—THRB—breast cancer	1.53e-05	0.000288	CbGpPWpGaD
Cyproterone acetate—Malnutrition—Epirubicin—breast cancer	1.53e-05	0.000141	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Docetaxel—breast cancer	1.53e-05	0.00014	CcSEcCtD
Cyproterone acetate—Nausea—Fluorouracil—breast cancer	1.53e-05	0.00014	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EGFR—breast cancer	1.53e-05	0.000287	CbGpPWpGaD
Cyproterone acetate—Eye disorder—Doxorubicin—breast cancer	1.52e-05	0.00014	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.52e-05	0.000286	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Methotrexate—breast cancer	1.52e-05	0.00014	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Docetaxel—breast cancer	1.52e-05	0.000139	CcSEcCtD
Cyproterone acetate—Anaemia—Methotrexate—breast cancer	1.51e-05	0.000139	CcSEcCtD
Cyproterone acetate—Tension—Epirubicin—breast cancer	1.5e-05	0.000138	CcSEcCtD
Cyproterone acetate—Diarrhoea—Paclitaxel—breast cancer	1.5e-05	0.000137	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ANGPTL4—breast cancer	1.5e-05	0.000281	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ESRRA—breast cancer	1.5e-05	0.000281	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—breast cancer	1.48e-05	0.000278	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Capecitabine—breast cancer	1.48e-05	0.000136	CcSEcCtD
Cyproterone acetate—Angiopathy—Doxorubicin—breast cancer	1.48e-05	0.000136	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—breast cancer	1.48e-05	0.000278	CbGpPWpGaD
Cyproterone acetate—Malaise—Methotrexate—breast cancer	1.48e-05	0.000136	CcSEcCtD
Cyproterone acetate—Immune system disorder—Doxorubicin—breast cancer	1.47e-05	0.000135	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—RXRB—breast cancer	1.47e-05	0.000276	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—TET2—breast cancer	1.47e-05	0.000276	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—DNMT3B—breast cancer	1.47e-05	0.000276	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Capecitabine—breast cancer	1.47e-05	0.000135	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Doxorubicin—breast cancer	1.47e-05	0.000135	CcSEcCtD
Cyproterone acetate—Abdominal pain—Docetaxel—breast cancer	1.47e-05	0.000135	CcSEcCtD
Cyproterone acetate—Body temperature increased—Docetaxel—breast cancer	1.47e-05	0.000135	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—breast cancer	1.47e-05	0.000135	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH2—breast cancer	1.46e-05	0.000275	CbGpPWpGaD
Cyproterone acetate—Chills—Doxorubicin—breast cancer	1.46e-05	0.000134	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—breast cancer	1.46e-05	0.000274	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—breast cancer	1.45e-05	0.000272	CbGpPWpGaD
Cyproterone acetate—Dizziness—Paclitaxel—breast cancer	1.45e-05	0.000133	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.44e-05	0.000271	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPL31—breast cancer	1.44e-05	0.000271	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—KRAS—breast cancer	1.44e-05	0.000271	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPL23A—breast cancer	1.44e-05	0.000271	CbGpPWpGaD
Cyproterone acetate—Alopecia—Doxorubicin—breast cancer	1.44e-05	0.000132	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—breast cancer	1.44e-05	0.00027	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—JUN—breast cancer	1.43e-05	0.00027	CbGpPWpGaD
Cyproterone acetate—Cough—Methotrexate—breast cancer	1.43e-05	0.000131	CcSEcCtD
Cyproterone acetate—Mental disorder—Doxorubicin—breast cancer	1.43e-05	0.000131	CcSEcCtD
Cyproterone acetate—Urticaria—Capecitabine—breast cancer	1.43e-05	0.000131	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	1.42e-05	0.000268	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NCOA1—breast cancer	1.42e-05	0.000267	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.42e-05	0.000267	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Epirubicin—breast cancer	1.42e-05	0.000131	CcSEcCtD
Cyproterone acetate—Body temperature increased—Capecitabine—breast cancer	1.42e-05	0.00013	CcSEcCtD
Cyproterone acetate—Abdominal pain—Capecitabine—breast cancer	1.42e-05	0.00013	CcSEcCtD
Cyproterone acetate—Malnutrition—Doxorubicin—breast cancer	1.42e-05	0.00013	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GPI—breast cancer	1.42e-05	0.000266	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HADHB—breast cancer	1.42e-05	0.000266	CbGpPWpGaD
Cyproterone acetate—Anaemia—Epirubicin—breast cancer	1.42e-05	0.00013	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—breast cancer	1.42e-05	0.000266	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HIST1H2BC—breast cancer	1.41e-05	0.000266	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HIST1H2BK—breast cancer	1.41e-05	0.000266	CbGpPWpGaD
Cyproterone acetate—Agitation—Epirubicin—breast cancer	1.41e-05	0.000129	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.41e-05	0.000264	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RARB—breast cancer	1.4e-05	0.000263	CbGpPWpGaD
Cyproterone acetate—Tension—Doxorubicin—breast cancer	1.39e-05	0.000128	CcSEcCtD
Cyproterone acetate—Vomiting—Paclitaxel—breast cancer	1.39e-05	0.000128	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.38e-05	0.000127	CcSEcCtD
Cyproterone acetate—Malaise—Epirubicin—breast cancer	1.38e-05	0.000127	CcSEcCtD
Cyproterone acetate—Rash—Paclitaxel—breast cancer	1.38e-05	0.000127	CcSEcCtD
Cyproterone acetate—Dermatitis—Paclitaxel—breast cancer	1.38e-05	0.000127	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—breast cancer	1.38e-05	0.000127	CcSEcCtD
Cyproterone acetate—Syncope—Epirubicin—breast cancer	1.37e-05	0.000126	CcSEcCtD
Cyproterone acetate—Leukopenia—Epirubicin—breast cancer	1.37e-05	0.000126	CcSEcCtD
Cyproterone acetate—Headache—Paclitaxel—breast cancer	1.37e-05	0.000126	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Docetaxel—breast cancer	1.37e-05	0.000125	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—AR—breast cancer	1.36e-05	0.000256	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.36e-05	0.000255	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALDH1A1—breast cancer	1.35e-05	0.000254	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALDH7A1—breast cancer	1.35e-05	0.000254	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—breast cancer	1.35e-05	0.000254	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Epirubicin—breast cancer	1.35e-05	0.000124	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—RPS4X—breast cancer	1.34e-05	0.000253	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPS7—breast cancer	1.34e-05	0.000252	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MED12—breast cancer	1.34e-05	0.000252	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPS8—breast cancer	1.34e-05	0.000252	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—breast cancer	1.34e-05	0.000252	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—breast cancer	1.34e-05	0.000251	CbGpPWpGaD
Cyproterone acetate—Cough—Epirubicin—breast cancer	1.34e-05	0.000123	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—breast cancer	1.33e-05	0.00025	CbGpPWpGaD
Cyproterone acetate—Asthenia—Docetaxel—breast cancer	1.33e-05	0.000122	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.33e-05	0.00025	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—EIF3A—breast cancer	1.32e-05	0.000249	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Capecitabine—breast cancer	1.32e-05	0.000121	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Doxorubicin—breast cancer	1.32e-05	0.000121	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—breast cancer	1.31e-05	0.000247	CbGpPWpGaD
Cyproterone acetate—Pruritus—Docetaxel—breast cancer	1.31e-05	0.000121	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methotrexate—breast cancer	1.31e-05	0.00012	CcSEcCtD
Cyproterone acetate—Anaemia—Doxorubicin—breast cancer	1.31e-05	0.00012	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Methotrexate—breast cancer	1.31e-05	0.00012	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—DNMT3A—breast cancer	1.3e-05	0.000245	CbGpPWpGaD
Cyproterone acetate—Agitation—Doxorubicin—breast cancer	1.3e-05	0.00012	CcSEcCtD
Cyproterone acetate—Nausea—Paclitaxel—breast cancer	1.3e-05	0.000119	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—breast cancer	1.3e-05	0.000119	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—FHL2—breast cancer	1.3e-05	0.000244	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NME1—breast cancer	1.3e-05	0.000244	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—UMPS—breast cancer	1.3e-05	0.000244	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PHGDH—breast cancer	1.3e-05	0.000244	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ADSL—breast cancer	1.3e-05	0.000244	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.3e-05	0.000119	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.29e-05	0.000243	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Methotrexate—breast cancer	1.29e-05	0.000119	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.29e-05	0.000242	CbGpPWpGaD
Cyproterone acetate—Discomfort—Epirubicin—breast cancer	1.29e-05	0.000118	CcSEcCtD
Cyproterone acetate—Asthenia—Capecitabine—breast cancer	1.29e-05	0.000118	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—ELL—breast cancer	1.29e-05	0.000242	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—breast cancer	1.28e-05	0.000241	CbGpPWpGaD
Cyproterone acetate—Malaise—Doxorubicin—breast cancer	1.28e-05	0.000117	CcSEcCtD
Cyproterone acetate—Anorexia—Methotrexate—breast cancer	1.27e-05	0.000117	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—HPSE—breast cancer	1.27e-05	0.000239	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LDHB—breast cancer	1.27e-05	0.000239	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BRIP1—breast cancer	1.27e-05	0.000239	CbGpPWpGaD
Cyproterone acetate—Syncope—Doxorubicin—breast cancer	1.27e-05	0.000117	CcSEcCtD
Cyproterone acetate—Pruritus—Capecitabine—breast cancer	1.27e-05	0.000117	CcSEcCtD
Cyproterone acetate—Leukopenia—Doxorubicin—breast cancer	1.27e-05	0.000117	CcSEcCtD
Cyproterone acetate—Diarrhoea—Docetaxel—breast cancer	1.27e-05	0.000117	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.26e-05	0.000238	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—breast cancer	1.25e-05	0.000236	CbGpPWpGaD
Cyproterone acetate—Oedema—Epirubicin—breast cancer	1.25e-05	0.000115	CcSEcCtD
Cyproterone acetate—Hypotension—Methotrexate—breast cancer	1.25e-05	0.000115	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Doxorubicin—breast cancer	1.25e-05	0.000114	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—breast cancer	1.24e-05	0.000234	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—breast cancer	1.24e-05	0.000233	CbGpPWpGaD
Cyproterone acetate—Cough—Doxorubicin—breast cancer	1.24e-05	0.000114	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR1—breast cancer	1.23e-05	0.000232	CbGpPWpGaD
Cyproterone acetate—Shock—Epirubicin—breast cancer	1.23e-05	0.000113	CcSEcCtD
Cyproterone acetate—Diarrhoea—Capecitabine—breast cancer	1.23e-05	0.000113	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SMAD4—breast cancer	1.23e-05	0.000231	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Epirubicin—breast cancer	1.23e-05	0.000113	CcSEcCtD
Cyproterone acetate—Dizziness—Docetaxel—breast cancer	1.23e-05	0.000113	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—VDR—breast cancer	1.23e-05	0.00023	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Epirubicin—breast cancer	1.22e-05	0.000112	CcSEcCtD
Cyproterone acetate—Tachycardia—Epirubicin—breast cancer	1.22e-05	0.000112	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—NOTCH4—breast cancer	1.22e-05	0.000229	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Epirubicin—breast cancer	1.21e-05	0.000112	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Epirubicin—breast cancer	1.21e-05	0.000111	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GSTA3—breast cancer	1.21e-05	0.000227	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCC1—breast cancer	1.21e-05	0.000227	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMMR—breast cancer	1.21e-05	0.000227	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.2e-05	0.000226	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.2e-05	0.00011	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.19e-05	0.000224	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH1—breast cancer	1.19e-05	0.000224	CbGpPWpGaD
Cyproterone acetate—Discomfort—Doxorubicin—breast cancer	1.19e-05	0.00011	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NCOR1—breast cancer	1.19e-05	0.000224	CbGpPWpGaD
Cyproterone acetate—Anorexia—Epirubicin—breast cancer	1.19e-05	0.00011	CcSEcCtD
Cyproterone acetate—Dyspnoea—Methotrexate—breast cancer	1.19e-05	0.000109	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—PABPC1—breast cancer	1.19e-05	0.000223	CbGpPWpGaD
Cyproterone acetate—Dizziness—Capecitabine—breast cancer	1.19e-05	0.000109	CcSEcCtD
Cyproterone acetate—Vomiting—Docetaxel—breast cancer	1.18e-05	0.000108	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—breast cancer	1.18e-05	0.000108	CcSEcCtD
Cyproterone acetate—Rash—Docetaxel—breast cancer	1.17e-05	0.000107	CcSEcCtD
Cyproterone acetate—Hypotension—Epirubicin—breast cancer	1.17e-05	0.000107	CcSEcCtD
Cyproterone acetate—Dermatitis—Docetaxel—breast cancer	1.17e-05	0.000107	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—PPARGC1B—breast cancer	1.17e-05	0.000219	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Methotrexate—breast cancer	1.16e-05	0.000107	CcSEcCtD
Cyproterone acetate—Headache—Docetaxel—breast cancer	1.16e-05	0.000107	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—HSPA1B—breast cancer	1.16e-05	0.000218	CbGpPWpGaD
Cyproterone acetate—Oedema—Doxorubicin—breast cancer	1.16e-05	0.000106	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—breast cancer	1.15e-05	0.000106	CcSEcCtD
Cyproterone acetate—Fatigue—Methotrexate—breast cancer	1.15e-05	0.000106	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—breast cancer	1.14e-05	0.000215	CbGpPWpGaD
Cyproterone acetate—Vomiting—Capecitabine—breast cancer	1.14e-05	0.000105	CcSEcCtD
Cyproterone acetate—Shock—Doxorubicin—breast cancer	1.14e-05	0.000105	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.14e-05	0.000214	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.14e-05	0.000214	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Doxorubicin—breast cancer	1.13e-05	0.000104	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Doxorubicin—breast cancer	1.13e-05	0.000104	CcSEcCtD
Cyproterone acetate—Rash—Capecitabine—breast cancer	1.13e-05	0.000104	CcSEcCtD
Cyproterone acetate—Dermatitis—Capecitabine—breast cancer	1.13e-05	0.000104	CcSEcCtD
Cyproterone acetate—Tachycardia—Doxorubicin—breast cancer	1.13e-05	0.000104	CcSEcCtD
Cyproterone acetate—Headache—Capecitabine—breast cancer	1.12e-05	0.000103	CcSEcCtD
Cyproterone acetate—Skin disorder—Doxorubicin—breast cancer	1.12e-05	0.000103	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Doxorubicin—breast cancer	1.12e-05	0.000103	CcSEcCtD
Cyproterone acetate—Dyspnoea—Epirubicin—breast cancer	1.12e-05	0.000102	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—DNMT3B—breast cancer	1.11e-05	0.000209	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PGR—breast cancer	1.11e-05	0.000209	CbGpPWpGaD
Cyproterone acetate—Anorexia—Doxorubicin—breast cancer	1.1e-05	0.000101	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CA9—breast cancer	1.1e-05	0.000207	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTA4—breast cancer	1.1e-05	0.000207	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—breast cancer	1.1e-05	0.000207	CbGpPWpGaD
Cyproterone acetate—Nausea—Docetaxel—breast cancer	1.1e-05	0.000101	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Methotrexate—breast cancer	1.1e-05	0.000101	CcSEcCtD
Cyproterone acetate—Dyspepsia—Epirubicin—breast cancer	1.1e-05	0.000101	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.1e-05	0.000206	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPL23A—breast cancer	1.09e-05	0.000205	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—breast cancer	1.09e-05	0.0001	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—DNMT1—breast cancer	1.09e-05	0.000205	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.09e-05	0.000205	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Epirubicin—breast cancer	1.09e-05	9.99e-05	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—breast cancer	1.08e-05	0.000203	CbGpPWpGaD
Cyproterone acetate—Hypotension—Doxorubicin—breast cancer	1.08e-05	9.93e-05	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Epirubicin—breast cancer	1.08e-05	9.92e-05	CcSEcCtD
Cyproterone acetate—Fatigue—Epirubicin—breast cancer	1.08e-05	9.9e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.08e-05	0.000203	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPX2—breast cancer	1.07e-05	0.000202	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTA2—breast cancer	1.07e-05	0.000202	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—breast cancer	1.07e-05	0.000202	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HIST1H2BK—breast cancer	1.07e-05	0.000202	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HIST1H2BC—breast cancer	1.07e-05	0.000202	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NCOA2—breast cancer	1.07e-05	0.000201	CbGpPWpGaD
Cyproterone acetate—Constipation—Epirubicin—breast cancer	1.07e-05	9.82e-05	CcSEcCtD
Cyproterone acetate—Nausea—Capecitabine—breast cancer	1.07e-05	9.8e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—RARB—breast cancer	1.06e-05	0.0002	CbGpPWpGaD
Cyproterone acetate—Urticaria—Methotrexate—breast cancer	1.06e-05	9.75e-05	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.06e-05	0.0002	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SULT1A1—breast cancer	1.06e-05	0.000199	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPX4—breast cancer	1.06e-05	0.000199	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—EZH2—breast cancer	1.06e-05	0.000199	CbGpPWpGaD
Cyproterone acetate—Body temperature increased—Methotrexate—breast cancer	1.06e-05	9.7e-05	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—breast cancer	1.06e-05	9.7e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GSTA1—breast cancer	1.04e-05	0.000195	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—IDH1—breast cancer	1.04e-05	0.000195	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PARP1—breast cancer	1.03e-05	0.000194	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH3—breast cancer	1.03e-05	0.000194	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Doxorubicin—breast cancer	1.03e-05	9.48e-05	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Epirubicin—breast cancer	1.03e-05	9.47e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—NAT2—breast cancer	1.03e-05	0.000193	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Epirubicin—breast cancer	1.02e-05	9.39e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—MED12—breast cancer	1.02e-05	0.000192	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPS7—breast cancer	1.02e-05	0.000192	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPS8—breast cancer	1.02e-05	0.000192	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Doxorubicin—breast cancer	1.02e-05	9.36e-05	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—SERPINE1—breast cancer	1.01e-05	0.000191	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPS6—breast cancer	1.01e-05	0.00019	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Doxorubicin—breast cancer	1.01e-05	9.24e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—breast cancer	1e-05	0.000188	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Doxorubicin—breast cancer	9.99e-06	9.18e-05	CcSEcCtD
Cyproterone acetate—Fatigue—Doxorubicin—breast cancer	9.98e-06	9.16e-05	CcSEcCtD
Cyproterone acetate—Urticaria—Epirubicin—breast cancer	9.94e-06	9.13e-05	CcSEcCtD
Cyproterone acetate—Constipation—Doxorubicin—breast cancer	9.9e-06	9.09e-05	CcSEcCtD
Cyproterone acetate—Body temperature increased—Epirubicin—breast cancer	9.89e-06	9.08e-05	CcSEcCtD
Cyproterone acetate—Abdominal pain—Epirubicin—breast cancer	9.89e-06	9.08e-05	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Methotrexate—breast cancer	9.85e-06	9.04e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—ESR2—breast cancer	9.8e-06	0.000184	CbGpPWpGaD
Cyproterone acetate—Asthenia—Methotrexate—breast cancer	9.59e-06	8.81e-05	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Doxorubicin—breast cancer	9.54e-06	8.76e-05	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Doxorubicin—breast cancer	9.46e-06	8.69e-05	CcSEcCtD
Cyproterone acetate—Pruritus—Methotrexate—breast cancer	9.46e-06	8.69e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	9.37e-06	0.000176	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—breast cancer	9.31e-06	0.000175	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH2—breast cancer	9.28e-06	0.000174	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	9.27e-06	0.000174	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH4—breast cancer	9.23e-06	0.000174	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Epirubicin—breast cancer	9.21e-06	8.46e-05	CcSEcCtD
Cyproterone acetate—Urticaria—Doxorubicin—breast cancer	9.19e-06	8.44e-05	CcSEcCtD
Cyproterone acetate—Body temperature increased—Doxorubicin—breast cancer	9.15e-06	8.4e-05	CcSEcCtD
Cyproterone acetate—Abdominal pain—Doxorubicin—breast cancer	9.15e-06	8.4e-05	CcSEcCtD
Cyproterone acetate—Diarrhoea—Methotrexate—breast cancer	9.14e-06	8.4e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	9.05e-06	0.00017	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NCOA1—breast cancer	9.03e-06	0.00017	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DPYD—breast cancer	8.99e-06	0.000169	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MED12—breast cancer	8.99e-06	0.000169	CbGpPWpGaD
Cyproterone acetate—Asthenia—Epirubicin—breast cancer	8.97e-06	8.24e-05	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	8.97e-06	0.000168	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALDOA—breast cancer	8.85e-06	0.000166	CbGpPWpGaD
Cyproterone acetate—Pruritus—Epirubicin—breast cancer	8.85e-06	8.13e-05	CcSEcCtD
Cyproterone acetate—Dizziness—Methotrexate—breast cancer	8.84e-06	8.12e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—HSPA1B—breast cancer	8.81e-06	0.000166	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	8.67e-06	0.000163	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOA3—breast cancer	8.59e-06	0.000161	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Epirubicin—breast cancer	8.56e-06	7.86e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—SLC2A2—breast cancer	8.53e-06	0.00016	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Doxorubicin—breast cancer	8.53e-06	7.83e-05	CcSEcCtD
Cyproterone acetate—Vomiting—Methotrexate—breast cancer	8.5e-06	7.81e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—PGR—breast cancer	8.45e-06	0.000159	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.44e-06	0.000159	CbGpPWpGaD
Cyproterone acetate—Rash—Methotrexate—breast cancer	8.43e-06	7.74e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Methotrexate—breast cancer	8.42e-06	7.73e-05	CcSEcCtD
Cyproterone acetate—Headache—Methotrexate—breast cancer	8.37e-06	7.69e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CPT1A—breast cancer	8.36e-06	0.000157	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCG2—breast cancer	8.36e-06	0.000157	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTR—breast cancer	8.36e-06	0.000157	CbGpPWpGaD
Cyproterone acetate—Asthenia—Doxorubicin—breast cancer	8.3e-06	7.63e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—DNMT1—breast cancer	8.28e-06	0.000156	CbGpPWpGaD
Cyproterone acetate—Dizziness—Epirubicin—breast cancer	8.27e-06	7.6e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—HPGDS—breast cancer	8.2e-06	0.000154	CbGpPWpGaD
Cyproterone acetate—Pruritus—Doxorubicin—breast cancer	8.19e-06	7.52e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—HBA1—breast cancer	8.14e-06	0.000153	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NCOA2—breast cancer	8.13e-06	0.000153	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—EZH2—breast cancer	8.02e-06	0.000151	CbGpPWpGaD
Cyproterone acetate—Vomiting—Epirubicin—breast cancer	7.95e-06	7.3e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ACHE—breast cancer	7.95e-06	0.000149	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTT1—breast cancer	7.95e-06	0.000149	CbGpPWpGaD
Cyproterone acetate—Nausea—Methotrexate—breast cancer	7.94e-06	7.29e-05	CcSEcCtD
Cyproterone acetate—Diarrhoea—Doxorubicin—breast cancer	7.92e-06	7.27e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—SIRT1—breast cancer	7.89e-06	0.000148	CbGpPWpGaD
Cyproterone acetate—Rash—Epirubicin—breast cancer	7.89e-06	7.24e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Epirubicin—breast cancer	7.88e-06	7.24e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—PARP1—breast cancer	7.85e-06	0.000148	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH3—breast cancer	7.85e-06	0.000148	CbGpPWpGaD
Cyproterone acetate—Headache—Epirubicin—breast cancer	7.84e-06	7.2e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—SMAD4—breast cancer	7.79e-06	0.000146	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—VDR—breast cancer	7.78e-06	0.000146	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	7.7e-06	0.000145	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPS6—breast cancer	7.66e-06	0.000144	CbGpPWpGaD
Cyproterone acetate—Dizziness—Doxorubicin—breast cancer	7.65e-06	7.03e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—NCOR1—breast cancer	7.57e-06	0.000142	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP17A1—breast cancer	7.52e-06	0.000141	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS1—breast cancer	7.45e-06	0.00014	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ENO1—breast cancer	7.45e-06	0.00014	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR2—breast cancer	7.44e-06	0.00014	CbGpPWpGaD
Cyproterone acetate—Nausea—Epirubicin—breast cancer	7.43e-06	6.82e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.42e-06	0.000139	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—H2AFX—breast cancer	7.37e-06	0.000139	CbGpPWpGaD
Cyproterone acetate—Vomiting—Doxorubicin—breast cancer	7.36e-06	6.76e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.33e-06	0.000138	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2D6—breast cancer	7.3e-06	0.000137	CbGpPWpGaD
Cyproterone acetate—Rash—Doxorubicin—breast cancer	7.3e-06	6.7e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Doxorubicin—breast cancer	7.29e-06	6.7e-05	CcSEcCtD
Cyproterone acetate—Headache—Doxorubicin—breast cancer	7.25e-06	6.66e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—NCOA2—breast cancer	7.17e-06	0.000135	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ERCC2—breast cancer	7.11e-06	0.000134	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH2—breast cancer	7.04e-06	0.000132	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—FASN—breast cancer	6.95e-06	0.000131	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BCHE—breast cancer	6.92e-06	0.00013	CbGpPWpGaD
Cyproterone acetate—Nausea—Doxorubicin—breast cancer	6.87e-06	6.31e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—NCOA1—breast cancer	6.85e-06	0.000129	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC5A5—breast cancer	6.84e-06	0.000129	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NQO1—breast cancer	6.61e-06	0.000124	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC2A1—breast cancer	6.61e-06	0.000124	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AR—breast cancer	6.57e-06	0.000123	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.47e-06	0.000122	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP3A4—breast cancer	6.44e-06	0.000121	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—breast cancer	6.42e-06	0.000121	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.41e-06	0.00012	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1B1—breast cancer	6.33e-06	0.000119	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSP90AA1—breast cancer	6.21e-06	0.000117	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOA1—breast cancer	6.04e-06	0.000114	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SIRT1—breast cancer	5.99e-06	0.000113	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—STK11—breast cancer	5.95e-06	0.000112	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR1—breast cancer	5.94e-06	0.000112	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SMAD4—breast cancer	5.91e-06	0.000111	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—VDR—breast cancer	5.9e-06	0.000111	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH1—breast cancer	5.75e-06	0.000108	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NCOR1—breast cancer	5.74e-06	0.000108	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—H2AFX—breast cancer	5.59e-06	0.000105	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.59e-06	0.000105	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—COMT—breast cancer	5.54e-06	0.000104	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTP1—breast cancer	5.51e-06	0.000104	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMOX1—breast cancer	5.43e-06	0.000102	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ITPR1—breast cancer	5.42e-06	0.000102	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ERCC2—breast cancer	5.4e-06	0.000101	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCB1—breast cancer	5.22e-06	9.8e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TYMS—breast cancer	5.12e-06	9.63e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—breast cancer	5.06e-06	9.51e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOR1—breast cancer	5.06e-06	9.51e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLA2G4A—breast cancer	5.06e-06	9.51e-05	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SERPINE1—breast cancer	4.89e-06	9.18e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—breast cancer	4.87e-06	9.16e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPX1—breast cancer	4.85e-06	9.11e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1A1—breast cancer	4.8e-06	9.02e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ERCC2—breast cancer	4.76e-06	8.95e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR1—breast cancer	4.51e-06	8.47e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—breast cancer	4.47e-06	8.41e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH1—breast cancer	4.36e-06	8.19e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAV1—breast cancer	4.13e-06	7.76e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.94e-06	7.41e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CG—breast cancer	3.76e-06	7.06e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SERPINE1—breast cancer	3.71e-06	6.97e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CD—breast cancer	3.3e-06	6.21e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—breast cancer	3.26e-06	6.13e-05	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MAPK3—breast cancer	3.18e-06	5.97e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NOS3—breast cancer	3.12e-06	5.86e-05	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—breast cancer	3.09e-06	5.81e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CB—breast cancer	2.88e-06	5.41e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—breast cancer	2.85e-06	5.36e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTEN—breast cancer	2.49e-06	4.68e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MAPK3—breast cancer	2.41e-06	4.53e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—breast cancer	2.35e-06	4.41e-05	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—breast cancer	2.14e-06	4.03e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—breast cancer	1.76e-06	3.3e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—breast cancer	1.63e-06	3.06e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—breast cancer	1.43e-06	2.7e-05	CbGpPWpGaD
